Operating Lease, Right-of-Use Asset in USD of Galera Therapeutics, Inc. from Q3 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Galera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q3 2019 to Q4 2024.
  • Galera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $0, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 -$1,212,000 -100% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $0 -$1,249,000 -100% 30 Sep 2024 10-Q 13 Dec 2024 2024 Q3
Q2 2024 $1,136,000 -$150,000 -12% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,174,000 +$1,174,000 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,212,000 +$1,169,000 +2,719% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,249,000 +$1,143,000 +1,078% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,286,000 +$1,118,000 +665% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $0 -$229,000 -100% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $43,000 -$253,000 -85% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $106,000 -$268,000 -72% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $168,000 -$282,000 -63% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $229,000 -$297,000 -56% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $296,000 -$234,000 -44% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 $374,000 -$229,000 -38% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $450,000 -$225,000 -33% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $526,000 -$219,000 -29% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $530,000 -$285,000 -35% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $603,000 -$273,000 -31% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $675,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $745,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $815,000 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $876,000 30 Sep 2019 10-Q 10 Dec 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.